<- Go Home
Forward Pharma A/S
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Market Cap
$7.4M
Volume
358.00
Cash and Equivalents
$65.3M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$882.86
52 Week Low
$200.00
Dividend
N/A
Price / Book Value
0.12
Price / Earnings
-11.83
Price / Tangible Book Value
0.12
Enterprise Value
-$54.9M
Enterprise Value / EBITDA
N/A
Operating Income
-$3.9M
Return on Equity
0.83%
Return on Assets
-3.42
Cash and Short Term Investments
$65.3M
Debt
$2.9M
Equity
$62.1M
Revenue
N/A
Unlevered FCF
-$2.2M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium